Human immunodeficiency virus (HIV) attacks the immune system of the individual. The human immunodeficiency virus (HIV) is a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). AIDS refers to a set of symptoms and illnesses. It is one of the most widespread and incurable deficiency syndromes among humans across the world. HIV spreads through unprotected intercourse with a person infected with HIV. HIV can also be transmitted through transfusion of contaminated blood, from infected mother to child during breastfeeding and pregnancy, and due to sharing of contaminated needles and syringes. Some of the symptoms of HIV infection are swollen glands, headache, slight fever, fatigue, and muscle ache. At present, HIV infection can be treated by drugs that belong to classes such as nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), entry and fusion inhibitors, integrase inhibitors, and protease inhibitors (PIs). Truvada, Atripla, Stribild, and Prezista/Prezcobix are some of the key drugs available in the market for treating HIV/AIDS.

According to a WHO report, by the end of 2015, the number of people infected by HIV, globally, stood at 36.7 million. The global HIV/AIDS drugs market is expanding significantly due to increasing prevalence of the disease. Rise in the incidence of unprotected sex has led to increase in the prevalence of HIV/AIDS. Increase in funding from government and private sectors for the treatment of HIV/AIDS in terms of reimbursement is projected to drive the market during the forecast period. Low rate of voluntary screening for the disease is a major restraint for the market. Awareness about diagnostic tests for HIV infection is extremely low in countries in Africa. Hence, companies are facing challenges in penetrating the market in the region. Moreover, several low- and middle-income countries depend on government grants for provision of rapid diagnostic tests in the event of an epidemic. Therefore, their direct reach to customers is weak in these countries. These factors hamper the market in the region.

The global HIV/AIDS drugs market can be segmented based on drug class, distribution channel, and region. In terms of drug class, the market can be categorized into nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), entry & fusion inhibitors, integrase inhibitors, protease inhibitors (PIs), and combination class drugs. In terms of revenue, the combination class drugs segment held a significant share of the HIV/AIDS drug market in 2016. Atripla, Triumeq, and Truvada held a significant share of the market in 2016. In terms of distribution channel, the global HIV/AIDS drugs market can be classified into hospital pharmacies, retail pharmacies, online pharmacies, and others. In terms of revenue, the hospital pharmacies segment held a significant share of the HIV/AIDS drugs market in 2016.

In terms of region, the global HIV/AIDS drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the leading market for HIV/AIDS drugs. In terms of revenue, the U.S. holds a major share of the HIV/AIDS drugs market in North America. The market in Europe is expanding rapidly due to increase in the patient population in the region, especially in the U.K. and Germany. The market in Asia Pacific and Latin America is projected to expand significantly in the near future. Developing economies such as China and India are anticipated to contribute to growth of the market in Asia Pacific between 2017 and 2025, due to better health care infrastructure, economic growth, increase in the number of insurance payers, growth of the private health care sector, and increase in awareness among people in these countries.

Key players operating in the global HIV/AIDS drugs market are Gilead Sciences, Inc., GlaxoSmithKline plc, Merck & Co., Inc., Johnson & Johnson, Bristol-Myers Squibb Co., AbbVie Inc., Pfizer, Inc., Alexion Pharmaceuticals, and Shionogi.

This upcoming business intelligence report is intended to be a one-stop market research solution to guide organizations in taking timely and effective decisions for their business growth. The ongoing study is the culmination of our deep expertise on data science methods, combined with an unparalleled understanding of the external environment and analysis of the industries. Each of the reports by TMR aims at offering a detailed scrutiny of the value chain of our current and prospective customers, takes them from identifying value propositions, and subsequently assist their business executives to implement right strategies to create customer value. We believe that creating and sustaining the customer value is the key pivot on which business executives can create profits for their organizations and increase the market shares, continuously and with sustainability.

Each of our touchpoints through which we engage with the organization/enterprise during the primary research enables us to understand the internal environment it operates in and the ways in which the external environment influences its growth.

Always Evolving with Competition

Excellence is built into the DNA of TMR, and all our teams work collaboratively and committedly toward achieving that in whatever they do. From the very first interaction our teams of research analysts have with any interested market participant to the final preparation processes in each of our reports reflects a rigorous understanding of the dynamic industry environment that businesses operate in.

We relentlessly work to be a differentiator in whatever we do in the current era of hypercompetitive global environment. The result of our unceasing focus on excellence is reflected clearly in the insights and guidance we offer to our customers in order to empower them to create brand equity. Our simple yet very powerful underpinning for navigating the competition is to always keep evolving with changing business environments. Our close-kinit team of research analysts not only believe in this simple philosophy but also implement the same.

Constantly Innovating Our Research Methodologies and Models

We do not limit with any specific market research tool or one standard approach for obtaining or analyzing data. Undoubtedly, our report making process is ever-evolving to meet the customer needs and demands supported broadly by a vast knowledge of data science methods that we combine with business acumen our teams have built upon for several years. Evidently, our primary and secondary research data about customers and consumers have shown that we can go to any lengths to obtain them. This is followed by applying next-gen automation tools integrated with human judgement to clear the clutter, ascertain the most relevant and recent qualitative and quantitative insights, and package them in digestible chunks in our reports for our customers.

We Take Pride in No-One-Size-Fits-All Approach

Over the past several years, we have been conducting market intelligence studies across all industries for all types of organizations — big and small, profit and not-for-profit, and Fortune 500 and Unicorns, as we believe that a sound decision making must be based on no-one-size-fits-all approach. Without doubt, each of the organizations regardless of the industry they are in are affected differently by changes in political, economic, socio-culture, legal, ecological, and legal environments. The research models and the value chain analysis process that our analysts employ for conducting the study uphold this approach.

We look at myriad components of internal and external business environment affecting the growth strategies of organizations. Some of the broader aspects that we focus on are:

  • Our team of Analysts and Support Teams always strive to see the bigger picture in life cycle stages of any industry
  • The Teams focus on obtaining valuable insights into different models of competitive advantage while making an internal environment analysis
  • They keep on modifying the value chain analysis processes of organizations to understand on how customer value is created

Some areas of assessing market dynamics that are used in the research models and methodologies adopted by our analysts can be summarized as:

  • Corporate and business strategies underlying new brand positioning strategies
  • Mapping for strategic planning for business units
  • Various metrics for business portfolio analysis, including BCG matrix
  • Value chain analysis

These will help create and sustain competitive advantage for our prospects and current customers.

Key focus areas and agenda that underpin and catalyze our primary and secondary research initiatives and endeavors are:

  • What are some of the core competencies and distinctive competencies of new entrants and established players in the industry we are analyzing?
  • What are some of the branding opportunities that are emerging at a rapid pace?
  • What are the major competitive forces and elements of external environment shaping the industry life cycle stages of most organizations?
  • Why some competitive strategies are popular than others among leaders in a certain market?
  • What customer-based brand equity strategies companies have leveraged in a certain industry or set of related industries in a sector?
  • What are some of the key pricing strategies that companies in an industry are implementing for marketing their products internationally?
  • Identifying whether market-push or market-pull strategies are more relevant to a certain product or a service?

Disclaimer: This ongoing market research study is a meticulously planned activity where a broad array of factors and aspects that shape the marketing environment and industry are taken into account. However, keeping in mind the constantly changing nature of business dynamics and changing strategic intents, we are always actively making iterations and modifications in our approaches. As always, we are ready to tailor our insights and guidance to suit your requirements. Engage with us to know what more is there for your CXOs.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

HIV/AIDS Drugs Market